Effect of combined treatment of thioperamide with some antiepileptic drugs on methioninesulfoximine induced convulsions in mice

Indian Journal of Experimental Biology

Volumn 48, Issue 8, 2010, Pages 858-860

  Vohora, Divya ^a   Khanam, Razia ^a   Pal, Shanthi N ^b   Pillai, K K ^a  

^a HAMDARD UNIVERSITY   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Gabapentin; Methionine sulfoximine; Sodium valproate; Thioperamide

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; METHIONINE SULFOXIMINE; PIPERIDINE DERIVATIVE; THIOPERAMIDE; VALPROIC ACID;

ANIMAL; ARTICLE; BRAIN; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG EFFECT; MALE; MOUSE; SEIZURE;

AMINES; ANIMALS; ANTICONVULSANTS; BRAIN; CYCLOHEXANECARBOXYLIC ACIDS; DRUG COMBINATIONS; GAMMA-AMINOBUTYRIC ACID; MALE; METHIONINE SULFOXIMINE; MICE; PIPERIDINES; SEIZURES; VALPROIC ACID;

MUS;

EID: 77954975391     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Vohora D, Pal S N & Pillai K K, Histamine as an Anticonvulsant Inhibitory Neurotransmitter, Current Neuropharmacol, 2 (2004) 419.
2. Vohora D & Pillai K. K. Epilepsy, in The third histamine receptor selective ligands as potential therapeutic agents in CNS disorders, edited by D Vohora (CRC Press, Boca Raton) 2009, 305.
3. Arrang J M, Garbarg M & Schwartz J C, Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor, Nature 302 (1983) 1.
4. Harada C, Hirai T, Fujii Y, Harusawa S, Kurihara T & Kamei C, Intracerebroventricular administration of histamine H3 receptor antagonists decreases seizures in rat models of epilepsia, Meth Find Exp Clin Pharmacol, 4 (2004) 263.
5. Vohora D, Pal S N & Pillai K K, Thioperamide, a selective histamine H3-receptor antagonist, protects against PTZ-induced seizures in mice, Life Sci, 66 (2000) 297.
6. Schatz R A & Sellinger O Z, The elevation of cerebral histamine-N-and catechol-O-methyltransferaze activitied by L-methionine-dl-sulfoximine, J Neurochem, 25 (1975) 73.
7. Schayer R W & Railly M A, In vivo formation and catabolism of histamine in mouse brain, J Neurochem, 17 (1970) 1649.
8. Tuomisto L, Tacke U & William A, Inhibition of sound induced convulsions by metoprine in the audiogenic seizure susceptible rat, Agents and Actions, 20 (1987) 252.
9. Stone W E & Javid M J, Effects of prior administration of methionine-sulfoximine on the thresholds of seizures induced in mice by 3-mercaptopropionic acid or pentylene tetrazole, Biochem Pharmacol, 27 (1978) 2972.
10. Toussi H R, Schatz R A & Waszczak B L, Suppression of methionine sulfoximine seizures by intra-nigral gamma-vinyl injection, Eur JPharmacol, 137 (1987) 261.
11. Blizard D A & Balkoski V, Tryptophan availability, central serotonergic function and methionine-sulfoximine-induced convulsions, Neuropharmacol, 21 (1982) 27.
12. Haley T J & McCormic W G, Pharmacological effects produced by intracerebral injections of drugs in the conscious mice, Br J Pharmacol, 12 (1957) 12.
13. Vohora D, Pal S N & Pillai K K, Histamine and selective H3- receptor ligands: A possible role in the mechanism and management of epilepsy, Pharmacol Biochem Behav, 68 (2001) 735.
14. Kamei C, Ishizawa K, Kakinoki H & Fakunaga M, Histaminergic mechanisms in amygdaloid kindled seizures rats, Epilepsy Res, 30 (1998) 187.
15. Onodera K, Tumisto L, Tacke U & Airaksinen M, Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats, Meth Find Exp Clin Pharmacol, 14(1992) 13.
16. Olivier R & Tobias H, Methionine sulfoximine increases acetylcholine level in the rat brain: No relation with epileptogenesis, Neuroreport, 6 (1995) 2027.